In clinical trials, which phase enrolls the largest number of participants?

In clinical trials, which phase enrolls the largest number of participants?

• A. Phase I
• B. Phase II
• C. Phase III
• D. Phase IV

Answer: (C)

Phase III trials enroll the largest number of participants because these late-stage studies are designed to confirm a treatment’s efficacy and monitor safety in a broad, diverse patient population and across multiple sites. They require enough participants to achieve statistical power to detect meaningful differences and to robustly characterize safety in subgroups, which is essential for regulatory approval. Earlier phases focus on safety and dosing (Phase I) and initial efficacy signals in a smaller group (Phase II), so their enrollment is smaller. After approval, Phase IV studies may involve large populations too, but the peak enrollment for establishing approval typically occurs in the third phase.

Phase III trials enroll the largest number of participants because these late-stage studies are designed to confirm a treatment’s efficacy and monitor safety in a broad, diverse patient population and across multiple sites. They require enough participants to achieve statistical power to detect meaningful differences and to robustly characterize safety in subgroups, which is essential for regulatory approval. Earlier phases focus on safety and dosing (Phase I) and initial efficacy signals in a smaller group (Phase II), so their enrollment is smaller. After approval, Phase IV studies may involve large populations too, but the peak enrollment for establishing approval typically occurs in the third phase.